Clinical Trial Update: Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of TA-650 for Behçet's disease with special lesions has completed, with results posted in December 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behçet Disease
• Neuro-behçet Disease

Drugs mentioned

• TA-650

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Behcet's Disease, Behcet Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2016-12-16